GSK completes acquisition of IDRx
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...
Naturopathic Doctor News6 天
Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast
Learn about Pseudoangiomatous Stromal Hyperplasia (PASH) of the breast, its diagnosis, hormonal influences, and holistic ...
Pharmabiz5 小时
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
eLife7 天
Synovial macrophage diversity and activation of M-CSF signaling in post-traumatic ...
Joint injury induces rapid and sustained diversification of resident and infiltrating synovial macrophage phenotypes, underpinning osteoarthritis-associated synovitis.